(2006)
Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia.
Nat Protoc 1(6),
2767-2773.
Publikationen
(2006)
In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans.
Mycoses 49(3),
159-168.
(2006)
Characterisation of the laccase-encoding gene abr2 of the dihydroxynaphthalene-like melanin gene cluster of Aspergillus fumigatus.
Arch Microbiol 186(5),
345-355.
(2006)
Inotilone and related phenylpropanoid polyketides from Inonotus sp. and their identification as potent COX and XO inhibitors.
Org Biomol Chem 4(13),
2545-2548.
(2005)
Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes.
J Antimicrob Chemother 55(5),
645-654.
(2005)
CandidaDB: a genome database for Candida albicans pathogenomics.
Nucleic Acids Res 33(Database issue),
D353-D357.
(2005)
Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood.
Mol Microbiol 56(2),
397-415.
(2005)
Generation and functional in vivo characterization of a lipid kinase defective phosphatidylinositol 3-kinase Vps34p of Candida albicans.
Microbiology 151(Pt 1),
81-89.
(2005)
Biotechnological production and bioactivities of mollisin and two new, structurally related fungal naphthoquinone metabolites.
Chem Biodivers 2(8),
1109-1115.
(2005)
Functional analysis of the phospholipase C gene CaPLC1 and two unusual phospholipase C genes, CaPLC2 and CaPLC3, of Candida albicans.
Microbiology 151(Pt 10),
3381-3394.